ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Yuhong Zhou
Matched on ORCID iD 0009-0009-3297-0873; OpenAlex author ID A5019910708. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2022: 1 paper · 2023: none · 2024: 2 papers
Papers 3
- Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.13643↗
- Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial. Last author DOI 10.3892/ol.2024.14293↗
- Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound. Co-author DOI 10.3390/diagnostics12112662↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yefei Rong · 2 shared papers, 2024 · strength 0.33
- Paper Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarci… DOI 10.1002/1878-0261.13643↗
- Paper Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase … DOI 10.3892/ol.2024.14293↗
- Dansong Wang · 2 shared papers, 2024 · strength 0.33
- Paper Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarci… DOI 10.1002/1878-0261.13643↗
- Paper Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase … DOI 10.3892/ol.2024.14293↗
- Tiantao Kuang · 2 shared papers, 2024 · strength 0.33
- Paper Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarci… DOI 10.1002/1878-0261.13643↗
- Paper Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase … DOI 10.3892/ol.2024.14293↗
- Wenchuan Wu · 2 shared papers, 2024 · strength 0.33
- Paper Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarci… DOI 10.1002/1878-0261.13643↗
- Paper Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase … DOI 10.3892/ol.2024.14293↗
- Xi Guo · 2 shared papers, 2022–2024 · strength 0.31
- Paper Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase … DOI 10.3892/ol.2024.14293↗
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662↗
- Suizhi Gao · 1 shared paper, 2024 · strength 0.17
- Guochao Zhao · 1 shared paper, 2024 · strength 0.17
- Wenhui Lou · 1 shared paper, 2024 · strength 0.17
- Gang Jin · 1 shared paper, 2024 · strength 0.17
- Lie Yao · 1 shared paper, 2024 · strength 0.16
- Xuefeng Xu · 1 shared paper, 2024 · strength 0.16
- Yaolin Xu · 1 shared paper, 2024 · strength 0.16
- Tianshu Liu · 1 shared paper, 2024 · strength 0.16
- Yuan Ji Ma · 1 shared paper, 2024 · strength 0.16
- Lili Wu · 1 shared paper, 2024 · strength 0.16
- Wenquan Wang · 1 shared paper, 2024 · strength 0.16
- Liang Liu · 1 shared paper, 2024 · strength 0.16
- Wenhui Lou · 1 shared paper, 2024 · strength 0.16
- Dayong Jin · 1 shared paper, 2024 · strength 0.16
- Jing Liu · 1 shared paper, 2024 · strength 0.16
- Jun Zhang · 1 shared paper, 2024 · strength 0.16
- Deliang Fu · 1 shared paper, 2024 · strength 0.16
- Xiaowei Liu · 1 shared paper, 2024 · strength 0.16
- Dan Zuo · 1 shared paper, 2022 · strength 0.15
- Qi Zhang · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.